Market cap
$11,513 Mln
Revenue (TTM)
$3,101 Mln
P/E Ratio
19.8
P/B Ratio
2.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
11.4 %
-
Industry P/E
45.4
-
EV/EBITDA
12.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$4.3
-
Face value
--
-
Shares outstanding
113,314,529
10 Years Aggregate
CFO
$1,783.21 Mln
EBITDA
$2,403.17 Mln
Net Profit
$1,293.16 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Globus Medical (GMED)
| -2.2 | -10.0 | -11.3 | 44.8 | 17.2 | 3.8 | 13.7 |
|
BSE Sensex
| -10.2 | -0.9 | -7.6 | -7.0 | 7.1 | 8.5 | 11.4 |
|
S&P Midcap 400
| 11.2 | 1.7 | 3.1 | 24.5 | 14.8 | 6.7 | 9.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Globus Medical (GMED)
| 5.6 | 54.7 | -28.2 | 2.9 | 10.7 | 10.8 | 36.0 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | -14.5 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Globus Medical (GMED)
|
85.4 | 11,512.5 | 3,100.6 | 586.7 | 19.5 | 12.9 | 19.8 | 2.4 |
| 86.7 | 152,251.9 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 24.5 | 2.9 | |
| 19.5 | 9,905.9 | 11,320.0 | -1,098.0 | -2.0 | -16.5 | -- | 1.6 | |
| 292.1 | 7,700.4 | 2,589.9 | 168.8 | 21.4 | 2.5 | 47.9 | 1.1 | |
| 74.2 | 8,453.8 | 13,384.0 | 395.0 | 5.2 | 11.2 | 22.4 | 2.6 | |
| 154.9 | 10,727.0 | 2,900.9 | 302.8 | 15.9 | 22.5 | 36.3 | 8.3 | |
| 439.3 | 155,158.7 | 10,582.1 | 2,979.1 | 22.4 | 17.2 | 53.2 | 8.9 | |
| 26.9 | 25,656.9 | 18,305.6 | 995.7 | 8.6 | 9.1 | 23.2 | 1.9 | |
| 132.7 | 5,876.9 | 2,811.2 | -1,008.8 | -7.9 | -29.2 | 1896.4 | 1.9 | |
| 448.2 | 166,590.5 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 24.6 | 3.2 |
Shareholding Pattern
View DetailsAbout Globus Medical (GMED)
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle... screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Address: 2560 General Armistead Avenue, Audubon, PA, United States, 19403-5214 Read more
-
Co-Founder & Executive Chairman
Mr. David C. Paul
-
Co-Founder & Executive Chairman
Mr. David C. Paul
-
Headquarters
Audubon, PA
-
Website
FAQs for Globus Medical (GMED)
What is the current share price of Globus Medical (GMED) Today?
The share price of Globus Medical (GMED) is $85.36 (NYSE) as of 26-May-2026 12:44 EDT. Globus Medical (GMED) has given a return of 17.17% in the last 3 years.
What is the current PB & PE ratio of Globus Medical (GMED)?
The P/E ratio of Globus Medical (GMED) is 19.82 times as on 22-May-2026, a 56 discount to its peers’ median range of 45.40 times.
The P/B ratio of Globus Medical (GMED) is 2.43 times as on 22-May-2026, a 22 discount to its peers’ median range of 3.11 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
22.27
|
2.62
|
|
2024
|
112.21
|
2.77
|
|
2023
|
60.29
|
1.85
|
|
2022
|
39.92
|
4.11
|
|
2021
|
50.42
|
4.32
|
What is the 52 Week High and Low of Globus Medical (GMED)?
The 52-week high and low of Globus Medical (GMED) are Rs 101.40 and Rs 51.79 as of 26-May-2026.
What is the market cap of Globus Medical (GMED)?
Globus Medical (GMED) has a market capitalisation of $ 11,513 Mln as on 22-May-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Globus Medical (GMED)?
Before investing in Globus Medical (GMED), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.